He L - Search Results

1

Assessment of induction chemotherapy regimen TPF vs GP followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A retrospective cohort study of 160 patients.

Guan H, He Y, Wei Z, Wang J, He L, Mu X, Peng X. Guan H, et al. Among authors: he y, he l. Clin Otolaryngol. 2020 Mar;45(2):274-279. doi: 10.1111/coa.13489. Epub 2019 Dec 13. Clin Otolaryngol. 2020. PMID: 31788988 No abstract available.

2

The Tumor Target Segmentation of Nasopharyngeal Cancer in CT Images Based on Deep Learning Methods.

Li S, Xiao J, He L, Peng X, Yuan X. Li S, et al. Among authors: he l. Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819884561. doi: 10.1177/1533033819884561. Technol Cancer Res Treat. 2019. PMID: 31736433 Free PMC article.

3

Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.

Wang J, Wang Y, He Y, Guan H, He L, Mu X, Peng X. Wang J, et al. Among authors: he y, he l. Trials. 2019 Nov 21;20(1):641. doi: 10.1186/s13063-019-3741-5. Trials. 2019. PMID: 31752981 Free PMC article.

4

Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis.

He Y, Zhao Z, Wang Y, Chai J, He J, Wang J, He L, Guan H, Wei Z, Liu Z, Mu X, Peng X. He Y, et al. Among authors: he j, he l. Head Neck. 2020 Aug;42(8):2067-2076. doi: 10.1002/hed.26141. Epub 2020 Mar 23. Head Neck. 2020. PMID: 32202686

5

Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.

Wang J, Yan L, Ai P, He Y, Guan H, Wei Z, He L, Mu X, Liu Y, Peng X. Wang J, et al. Among authors: he y, he l. Neurosurg Rev. 2021 Jun;44(3):1447-1455. doi: 10.1007/s10143-020-01326-y. Epub 2020 Jun 11. Neurosurg Rev. 2021. PMID: 32529528

6

Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience.

He L, Xiao J, Wei Z, He Y, Wang J, Guan H, Mu X, Peng X. He L, et al. Among authors: he y. Oral Oncol. 2020 Aug 27;109:104978. doi: 10.1016/j.oraloncology.2020.104978. Online ahead of print. Oral Oncol. 2020. PMID: 32861986

7

Prognostic nomogram for adenoid cystic carcinoma in different anatomic sites.

Mu X, Li Y, He L, Guan H, Wang J, Wei Z, He Y, Liu Z, Li R, Peng X. Mu X, et al. Among authors: he y, he l. Head Neck. 2021 Jan;43(1):48-59. doi: 10.1002/hed.26443. Epub 2020 Aug 30. Head Neck. 2021. PMID: 32864833

8

Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.

Wei ZG, Hu XL, He Y, Guan H, Wang JJ, He L, Mu XL, Liu ZR, Li RD, Peng XC. Wei ZG, et al. Among authors: he y, he l. Head Neck. 2021 May;43(5):1465-1475. doi: 10.1002/hed.26608. Epub 2021 Jan 9. Head Neck. 2021. PMID: 33421240

9

Comparative efficacy and safety of immunotherapy in the first-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis.

Liu Z, Chen Y, Wei Z, He Y, Wang J, Mu X, He L, Li R, Hu X, Peng X. Liu Z, et al. Among authors: he y, he l. Ann Palliat Med. 2021 Mar;10(3):2805-2814. doi: 10.21037/apm-20-1884. Epub 2020 Feb 7. Ann Palliat Med. 2021. PMID: 33615806 Free article.

10

Assessment of different induction chemotherapy regimens in locally advanced nasopharyngeal carcinoma: Meta-analysis.

Guan H, He Y, Su Y, Wei Z, Liu Z, Wang J, He L, Mu X, Li R, Hu X, Peng X. Guan H, et al. Among authors: he y, he l. Head Neck. 2021 Aug;43(8):2332-2341. doi: 10.1002/hed.26699. Epub 2021 Mar 31. Head Neck. 2021. PMID: 33792110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,130 results

Search Page

Filters